Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis

At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting for nearly a third of those rounds. The cuts were accompanied by eight biotech closures as the sector faces deep uncertainty tied to recent geopolitical changes.